Advancing novel therapeutics
Product Development Solutions
Holburn actively supports international companies with new product development, with unparalleled expertise in animal models for peripherally active psychedelic and cannabinoid compounds.
We offer product development solutions in the following novel therapeutic areas:
Psychedelics (e.g., psilocybin, ketamine, MDMA)
Cannabinoids (e.g., THC, CBD)
Can’t find what you’re looking for? Please see our Laboratory Science Solutions, our Consulting Solutions, or our Clinical Trials Solutions.
The future of healthcare diagnostics & therapeutics
From early diagnosis to tailored treatment, in the future of healthcare diagnostics and therapeutics, anything is possible.
Join us in shaping the future — contact us to find out how.